Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Biomarkers, Tumor
  • Breast Neoplasms

abstract

  • Molecular markers may be used to predict the likelihood of achieving GCR, which seems to be a valid surrogate marker for survival.

publication date

  • October 1999

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 10506600

Additional Document Info

start page

  • 3058

end page

  • 63

volume

  • 17

number

  • 10